Deutsche Bank Upgrades AstraZeneca (AZN:LN) (AZN) to Hold
Deutsche Bank analyst Emmanuel Papadakis upgraded AstraZeneca (AZN:LN) (NASDAQ: AZN) from Sell to Hold with a price target of GBP117.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

